A new antibody therapy developed at Stanford Medicine has shown that it can prepare patients for stem cell transplants without the need for toxic chemotherapy or radiation, according to results from a phase 1 clinical trial.
The study focused on…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply